AnalystsYanni SouroutzidisYanni Souroutzidis's Stock Forecasts
AnalystsYanni Souroutzidis
Sectors:
Industries:
Analyst Ranking
Bottom 17%
#4622 out of 5556 analysts
Average Return
-17.3%
Win Rate
20%1 out of 5
Risk vs Reward
Poor
Good
Yanni Souroutzidis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunic IncIMUX | +4.59% | $7.41 | $7.75 | 2026-10-23 - 2026-11-06 | Strong Buy |
Yanni Souroutzidis Analyst Color
Get additional color on Yanni Souroutzidis's coverage of popular stocks
Yanni Souroutzidis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunic IncIMUX | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 18 days ago |
Eloxx Pharmaceuticals IncELOX | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | a month ago |
Sagimet Biosciences IncSGMT | 1 | Strong Buy | $10.71 | +8.73% | Initiates Coverage On | 2 months ago |
Agomab Therapeutics NvAGMB | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 3 months ago |
Satellos Bioscience IncMSLE | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 8 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.